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Abstract
Background: Although funding has supported the scale up of routine, opt-out HIV testing in the US, variance in
implementation mechanisms and barriers in high-burden jurisdictions remains unknown.
Methods: We conducted a survey of health care organizations in Washington, DC and Houston/Harris County to determine
number of HIV tests completed in 2011, policy and practices associated with HIV testing, funding mechanisms, and reported
barriers to testing in each jurisdiction and to compare results between jurisdictions.
Results: In 2012, 43 Houston and 35 DC HIV-testing organizations participated in the survey. Participants represented 85%
of Department of Health-supported testers in DC and 90% of Department of Health-supported testers in Houston. The
median number of tests per organization was 568 in DC and 1045 in Houston. Approximately 50% of organizations in both
DC and Houston exclusively used opt-in consent and most conducted both pre- and post-test counseling with HIV testing
(80% of organizations in DC, 70% in Houston). While the most frequent source of funding in DC was the Department of
Health, Houston organizations primarily billed the patient or third-party payers. Barriers to testing most often reported were
lack of funding, followed by patient discomfort/refusal with more barriers reported in DC.
Conclusions: Given unique policies, resources and programmatic contexts, DC and Houston have taken different
approaches to support routine testing. Many organizations in both cities reported opt-in consent approaches and pre-test
counseling, suggesting 2006 national HIV testing recommendations are not being followed consistently. Addressing the
barriers to testing identified in each jurisdiction may improve expansion of testing.
Citation: Hallmark CJ, Skillicorn J, Giordano TP, Davila JA, McNeese M, et al. (2014) HIV Testing Implementation in Two Urban Cities: Practice, Policy, and
Perceived Barriers. PLoS ONE 9(10): e110010. doi:10.1371/journal.pone.0110010
Editor: Eliseo A. Eugenin, Rutgers University, United States of America
Received June 9, 2014; Accepted September 10, 2014; Published October 13, 2014
Copyright:  2014 Hallmark et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data used in the generation of this
article may be accessed online in a public repository (http://dx.doi.org/10.6084/m9.figshare.1050545).
Funding: This study was supported by a supplement to the National Institutes of Health-funded Baylor College of Medicine-University of Texas Houston Center
for AIDS Research (Grant Number P30AI036211, www.nih.gov, TPG, JAD), the District of Columbia Developmental Center for AIDS Research (Grant Number
P30AI087714, www.nih.gov, JS, ADC), the Centers for Disease Control and Prevention (Grant Number 5U62PS000775-03, www.cdc.gov, CJH, MM), and the facilities
and resources of the Department of Veterans Affairs (www.va.gov, TPG, JAD). The opinions expressed are those of the authors and not the National Institutes of
Health, the Department of Veterans Affairs or the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: camden.hallmark@houstontx.gov
Introduction
HIV testing is an important step of the HIV care continuum
and a critical component of prevention programs throughout the
United States (US). Nationally, an estimated 18% of infected
persons remain undiagnosed. [1] Awareness of HIV infection
decreases risk-taking behaviors, [2] with earlier initiation of care
resulting in decreased HIV-associated morbidity and mortality.
[3,4] In 2006, the US Centers for Disease Control and Prevention
(CDC) released revised recommendations for routine, opt-out HIV
screening in healthcare settings. Specifically, the revised recom-
mendations include screening patients for HIV using an opt-out
approach, the elimination of a separate written consent for HIV
testing, and optional pre-testing prevention counseling. [5]
CDC funding has since supported the scale up of routine, opt-
out screening nationwide, [6] yet implementation varies widely by
jurisdiction as each determines how to expand testing given
diverse contexts. Initiatives to scale up testing have included social
marketing campaigns in Miami, FL and Oakland, CA, door-to-
door testing outreach in San Diego, CA and Philadelphia, PA, [7]
and policy change to mandate the offer of HIV testing in primary
care settings in New York State. [8] Some models, such as that of
the Bronx Knows HIV Testing Initiative, have demonstrated
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success through combination approaches in partnership with the
local community and clinical providers. [7,9]
This article reports on some of the similarities and differences in
HIV testing observed in two jurisdictions highly impacted by HIV,
Washington DC and Houston, TX. The jurisdictions are two of
the twelve urban areas that represent 44% of the nation’s AIDS
cases. [10] DC has a generalized epidemic with 14,465 living
HIV/AIDS cases and a prevalence of 2.7%, and Houston has
19,943 living HIV/AIDS cases and a concentrated epidemic with
a prevalence of 0.6%. [11–13] Each jurisdiction’s local epidemic
and the associated policies, programmatic priorities, and resources
that influence testing implementation are reported in Table 1.
Policy in both jurisdictions has been relatively permissive of the
expansion of routine HIV testing. Statutes relevant to the 2006
recommendations in DC and Texas were either neutral or
consistent with all routine, opt-out recommendations. [14]
Specifically, in DC, there are no regulations requiring written
consent or pre/post-test counseling. The Insurance Coverage for
HIV Testing in Emergency Departments (ED) Amendment Act,
which was passed in 2008, attempts to facilitate third party
coverage of testing in DC EDs. Under Texas Health and Safety
Code, informed consent for HIV testing may be verbal as long as
test explanation and consent are documented in a patient’s
medical record. Additionally, an opt-out approach is required by
statute for pregnant women, where HIV screening is required at
the first visit and during the third trimester. No statute requires
pre-test prevention counseling and post-test counseling is only
required upon delivery of a positive test result. [15–17]
Since 2006, the DC Department of Health (DOH) has
supported targeted testing and routine, opt-out HIV testing
implementation as a standard of care in health care settings.
[18,19] The DOH began this initiative by providing free rapid test
kits and funding to testing programs at community-based
organizations (CBOs), clinics, DC Department of Corrections,
hospitals, and EDs. Between 2007 and 2008, DC expanded testing
to additional hospitals, primary medical settings, managed care
organizations, and CBOs. [20] The ‘‘Ask for the Test/Offer the
Test’’ initiative launched in 2009 to educate providers on how to
establish routine HIV testing protocols that emphasize the use of
standard blood panels. The DOH also engaged the DC
Department of Health Care Finance on promoting standard
HIV testing as part of the DC Medicaid and Alliance programs. In
Table 1. HIV Prevalence, Testing Policies and Programs by City.
Washington, DC Houston, TXa
Local Data
Population (persons $13 yrs; Census estimates
for 2010)
528,109 3,249,542
Number of living HIV/AIDS Cases $13 yrs
(reported as of 2010)
14,465 19,943
HIV/AIDS Prevalence Rate (as of 2010) 2.7 0.6
Type of epidemic Generalized Concentrated
Testing Guidance & Policies
Initiation of support for routine testing (year) 2006 2008
HIV testing consent and counseling regulations
or statutes
No Chapter 81 of Texas Health and Safety Codeb
Mandatory HIV testing Mandatory testing of convicted sex
offenders within the criminal justice
system
Mandatory testing of all offenders upon entry and release within
Texas Department of Criminal Justice Texas law allows for
mandatory testing in county and municipal jails
Texas law allows for mandatory testing in county and municipal jails
Established HIV testing reimbursement and
billing laws or regulations (year)
Insurance Coverage for HIV Testing in
Emergency Departments Amendment
Act (2008)
No specific laws on reimbursement or billing
Programming & Resources
Estimated number of annual publically-funded
HIV tests conducted
129,464 (2011) 107,458 (2011)
Testing campaigns/Programmatic initiatives/
Research activities to scale-up HIV testing
Come Together DC Get Screened for
HIV (2006)
HIP HOP for HIV Awareness (2007)
Ask for the Test/Offer the Test (2009) Expanded Testing Initiative (2008)
Enhanced Comprehensive HIV
Prevention Planning Initiative (2010)
Routine Screening for HIV- Memorial Hermann Health System and
Project RUSH at Harris Health System (2008)
HIV Prevention Trials Network 065
(intervention community) (2010)
Enhanced Comprehensive HIV Prevention Planning Initiative (2010)
HIV Prevention Trials Network 065 (control community) (2010)
aJurisdiction is Houston/Harris County. Population data are for Harris County.
bSince 1999, opt-out HIV testing has been required by Texas law during pregnancy at the first prenatal visit and at delivery. As of 2010, opt-out HIV testing is required
during the third trimester. If no record of third trimester testing is found, opt-out testing at time of delivery is required. For all other persons (not incarcerated), general
written consent for HIV testing is allowable. Informed consent may be verbal as long as test explanation and consent is documented in patient’s medical record. Opt-in
versus opt-out approach is not specified.
doi:10.1371/journal.pone.0110010.t001
HIV Testing Implementation in Two Urban Cities
PLOS ONE | www.plosone.org 2 October 2014 | Volume 9 | Issue 10 | e110010
2010, DC DOH received funding from NIH as an intervention
community for the HIV Prevention Trials Network (HPTN) Study
065 to support enhanced routine HIV testing and assess the
feasibility of a test and treat strategy. [21] DC’s DOH funded over
129,000 HIV tests in 2011, including the provision of over
122,000 rapid test kits.
In Houston, the CDC-funded Expanded Testing Initiative
(ETI) started in 2008 when the Houston Department of Health
and Human Services (HDHHS) began supporting routine, opt-out
HIV testing in the EDs of two large hospitals and two community
health centers. The Initiative grew to encompass four large EDs by
2009. With funding from the Texas Department of State Health
Services (DSHS), routine testing was further expanded in 2010 to
five additional EDs and twelve additional community health
centers. Targeted testing was also funded by the HDHHS at
CBOs for outreach to high risk populations and geographic areas.
In 2011, the HDHHS funded over 107,000 tests in the Houston
area.
Both DC and Houston health departments have provided
support for the provision and funding of HIV testing in
community and health care settings, including implementation
of social marketing campaigns. HIV testing and promotion of HIV
testing was further scaled up with the influx of HIV prevention
activities funded by the CDC’s Enhanced Comprehensive HIV
Prevention Planning (ECHPP) Project in both DC and Houston.
ECHPP was a 3-year demonstration project designed to improve
program planning and implementation in support of the National
HIV/AIDS Strategy. [22]
As part of ECHPP efforts, partnerships were formed between
academic institutions and public health departments to improve
program planning of HIV prevention activities in both DC and
Houston. These partnerships ensured that local research capacity
was improved and policy and programming stakeholders were
invested in the study’s outcomes, both of which are enabling
factors for success in operational research. [23] While operational
research has been utilized in low-income countries, [23,24] it has
been suggested that US jurisdictions could greatly benefit from
applying an operational research approach to identify barriers and
inform policy and decision-making in HIV prevention programs.
[25] Therefore, in response to ECHPP’s goal of improving
implementation, we used descriptive operational research to gain
knowledge of HIV testing implementation and organizational-
level testing barriers in Washington, DC and Houston, Texas.
Although implementation and barriers have been assessed among
EDs, health centers, or clinics, [26–28] assessment across different
types of organizations and jurisdictions has been limited. This
study examined implementation mechanisms, testing volume, and
organizational barriers for two cities with a high HIV/AIDS
burden and provides a comprehensive jurisdictional-level perspec-
tive on HIV testing.
Methods
Survey instrument
Surveys were designed to gather organizational-level data on
sites conducting HIV testing in each jurisdiction in 2011. Selected
survey questions were adapted from the National Association of
Community Health Centers survey on HIV testing, [29] a method
used previously in similar research. [30] In both DC and Houston,
organizations were questioned regarding their policies, funding,
implementation practices, testing volume, and barriers to testing
for calendar year 2011. Testing volume in 2011 was assessed by
each organization providing counts by test type. Review of
administrative and/or clinical data was the primary methodology
used for gathering this data (80.0% of organizations in DC and
81.4% of organizations in Houston), followed by estimates from
organizational staff members (17.1% DC and 11.6% Houston).
Barriers to HIV testing were assessed by asking respondents to
indicate the extent to which they agreed with possible barriers
using a 5-point scale ranging from no barrier (1) to major barrier
(5). Possible barriers included attitudinal conflicts, staff capacity,
and available resources and funding.
Sampling Frame
Sampling frames were designed to best fit the model of HIV
prevention activities unique to each jurisdiction. In DC, the
sampling strategy was developed through a partnership between
DC DOH and researchers at the George Washington University
as part of ECHPP. In 2011, DC DOH’s HIV/AIDS, Hepatitis,
STD, and TB Administration (HAHSTA)’s prevention model
primarily supported HIV testing through distribution of HIV
rapid test kits at no cost to approximately forty organizations. With
stakeholder and DOH input, it was determined that these
organizations conducted the vast majority of testing within the
city. Therefore, organizations were identified for survey inclusion
if their HIV testing services were HAHSTA-supported. These
organizations included CBOs, clinics, and hospitals.
In Houston, the sampling frame and sampling tool were
designed jointly by staff and researchers from HDHHS, Houston
Area HIV Services Ryan White Planning Council’s Office of
Support, and Baylor-UTHouston Center for AIDS Research, also
as part of ECHPP. The HDHHS funded two distinct HIV testing
services at 10 organizations in 2011: 1) targeted HIV testing by
CBOs that included prevention counseling, and 2) routine, opt-out
HIV testing in EDs and county clinics. HIV testing in Houston
was supported by a diverse mix of both public and private support,
thus sampled organizations included both those that were and
were not financially supported by the HDHHS. Utilizing a
methodology described previously, [31] an exhaustive list of
known HIV testing organizations was created from stakeholder
input. The list included CBOs, substance abuse treatment centers,
homeless shelters, hospitals, clinics and universities. This list was
then prioritized to focus on obtaining information from HDHHS
HIV prevention contractors, major public and private hospitals
and clinics, and known HIV testing organizations.
Survey Administration
In DC, surveys were emailed to HIV testing coordinators at
each organization. Confidential surveys were administered online
using Research Electronic Data Capture (REDCap). If no
response was received within one month of invitation, paper
surveys were mailed in addition to follow up phone calls.
Participants were compensated for survey completion.
In Houston, each organization was emailed a formal invitation
letter, followed by phone calls if there was no response via email.
Initial contact was with HIV program directors, nurse managers,
and/or lab directors. Respondents were selected based on their
authority to make HIV testing program decisions and/or their
knowledge of HIV testing activities within the organization. When
possible, surveys were completed by an in-person interview,
otherwise a telephone interview was conducted. Participants were
not compensated for survey completion.
Data Analysis
In DC, data collection and storage were via REDCap. Data
analysis was conducted using SAS 9.2 (SAS Institute, Cary, NC).
In Houston, all data were entered and managed in Excel. Data
analysis was conducted using SAS 9.3 (SAS Institute, Cary, NC).
HIV Testing Implementation in Two Urban Cities
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Summary data from both jurisdictions were compiled via Excel
and analyzed collaboratively by researchers from both jurisdic-
tions.
Consent
This study was approved by the Institutional Review Boards of
The George Washington University, the District of Columbia
Department of Health (Washington, DC) and the Baylor College
of Medicine (Houston). In Houston, the Institutional Review
Board approved verbal consent, with completion of the survey as
documentation of consent. Consent was also documented in a
secure database by the interviewer. Written consent would have
been the only record linking the participant and survey; therefore,
the potential harm resulting from a breach of confidentiality would
have increased since no other personal identifiers were gathered.
In DC, the Institutional Review Board approved the use of written
consent. The survey instructions asked participants to mark ‘‘yes’’
or ‘‘no’’ to indicate their consent to the survey prior to answering
any further questions. In both jurisdictions, the survey was
voluntary and deemed no more than minimal risk to participants.
Results
Respondents & Organizational Characteristics
In DC, 41 organizations were contacted for study inclusion. Of
these, 35 (85.4%) organizations participated in the survey,
representing 103 facilities that conducted HIV testing. Many of
the DC organizations were community-based organizations/
community service organizations (40.0%) (Table 2).
In Houston, 84 organizations were contacted for study
inclusion. Of these, 55 (65.5%) organizations participated in the
survey. Forty-three participating organizations, representing 114
facilities in the Houston/Harris County area, conducted HIV
testing. This analysis focused only on the 43 organizations
conducting HIV testing of which over half (51.2%) were outpatient
clinics or university health centers (Table 2).
Policy and Practices, Funding, and Testing Volume
The majority of organizations reported that a specific individual
coordinated HIV testing efforts for the organization. DC
organizations more frequently reported a coordinator than did
Houston (82.9% and 62.8%, respectively) (Table 2). Similarly,
82.9% of surveyed organizations in DC reported having a written
policy for HIV testing, while only 46.5% of surveyed organizations
in Houston reported having a policy for their organization.
The two jurisdictions reported similar approaches to provider
education about HIV testing. The top three sources of provider
education for DC were continuing education (74.3%), DOH or
clinic training (65.7%), and peer-to-peer best practices (57.1%).
Houston organizations most frequently identified DOH or clinic
training (58.1%), manuals/guidelines/literature (48.8%), and
continuing education (46.5%).
A similar proportion of organizations exclusively used an opt-in
consent approach in DC and Houston (51.4% and 48.8%
respectively). However, a substantial number of organizations in
Houston used a combination of opt-in and opt-out approaches
(44.2%). Further analysis revealed that 11.6% (n= 5) of organi-
zations in Houston using a combination approach only used opt-
out consent during pregnancy. While only three (7.0%) organiza-
tions in Houston reported using only the opt-out approach, 48.6%
of the surveyed organizations in DC exclusively used an opt-out
approach.
Despite CDC recommendations that removed the need for pre-
test counseling, most organizations in both jurisdictions reported
conducting both pre- and post-test counseling with HIV testing
(80.0% in DC and 69.8% in Houston). Very few organizations
reported conducting only post-test counseling (11.4% in DC and
16.3% in Houston).
For all HIV testing conducted by surveyed organizations, the
most frequent funding sources for DC were the DOH (74.3%),
research monies (34.3%), and federal funding other than that from
CDC and DOH (33.3%). In contrast, Houston organizations most
frequently identified the payer as the patient or the patient’s
insurance (65.1%), Medicaid (53.5%), Medicare (32.6%), and
other sources (32.6%) such as the organization’s general revenue
or funds received as donations. Funding specifically for routine,
opt-out HIV testing also varied between the two cities. The most
frequent funding source in DC was the DOH (68.6%), while
Houston organizations primarily paid for HIV testing by billing
the patient or patient’s insurance (54.5%) or Medicaid (50.0%).
The median total number of HIV tests performed per
organization in 2011 was higher in Houston than in DC (1045
and 568 respectively). While the total number of rapid tests
performed in DC was higher than in Houston (78,765 in DC vs.
40,910 in Houston), the median number of rapid tests performed
per organization was lower in DC than in Houston (593 vs. 1478).
Similarly, although the median number of venipuncture tests per
organization was higher in DC (1200 in DC vs. 585 in Houston),
the total number of venipuncture tests was higher in Houston than
in DC (169,635 in Houston vs. 4,558 in DC).
Barriers to HIV Testing
On a scale of 1 (no barrier) to 5 (major barrier), the highest
reported barriers to HIV testing in both DC and Houston were
patient discomfort/refusal (median score = 2) and lack of funding
for testing (median score = 3). When categorizing all items
dichotomously (no barrier vs. any barrier), DC organizations most
frequently selected ‘‘HIV not a problem for client population’’
(68.6% of organizations), ‘‘lack of funding’’ (60.0%), and ‘‘patient
discomfort or refusal for testing’’ (59.4%) as barriers (Figures 1–3).
Houston organizations most frequently selected ‘‘lack of funding’’
(59.5% of organizations), ‘‘patient discomfort or refusal for testing’’
(51.2%), and ‘‘staff knowledge, skill, experience’’ (41.9%).
In comparison to Houston organizations, DC organizations
more frequently reported every area as a barrier except for staff
knowledge, skill, experience (41.9% Houston vs. 32.4% DC) and
provider/staff resistance (20.9% vs. 20.6%) (Figures 1–3). How-
ever, 11 Houston organizations (25.6%) scored ‘‘other’’ barriers to
testing at 3 or higher, including managing data and/or paperwork
associated with testing and funding for testing (n = 4) and
challenges in contacting patients for results delivery and/or care
referrals (n = 3). The largest variances observed between the two
jurisdictions were ‘‘HIV is not a problem for the client population’’
(20.9% Houston vs. 68.6% DC), ‘‘limited staff time to provide
testing’’ (30.2% vs. 52.9%), and ‘‘limited staff size to provide
testing’’ (37.2% vs. 58.8%).
We examined whether barriers to testing implementation
differed by organization type (CBOs, hospitals, and clinics; data
not shown). Lack of funding was reported frequently across all
organizational types. Clinics were particularly challenged by cost
or reimbursement for testing and patient refusal, while CBOs
reported staff size as a barrier. Among hospitals, the highest
ranked barrier to testing in both jurisdictions was the perception
that HIV was not a problem in their client population. In DC,
barriers to testing were most frequently reported among hospitals
in comparison to other site types. The most frequent barriers
among DC hospitals included the perception that HIV is not a
problem in the client population (83.3% of organizations), staff
HIV Testing Implementation in Two Urban Cities
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Table 2. HIV Testing Policy, Funding, and Implementation Practices.
Washington, DC (N=35) Houston, TX (N=43)
N % N %
Type of organization
Hospital 12 34.3% 11 25.6%
Community-based or community service organizationa 14 40.0% 10 23.3%
Clinic or university health center 9 25.7% 22 51.2%
Individual at organization who coordinates HIV testing efforts
Yes 29 82.9% 27 62.8%
No 6 17.1% 16 37.2%
Have a written policy for HIV testing
Yes 29 82.9% 20 46.5%
No 6 17.1% 23 53.5%
How providers are educated about HIV testingc
Continuing education 26 74.3% 20 46.5%
DOH or clinic training 23 65.7% 25 58.1%
Peer-to-peer best practices 20 57.1% 17 39.5%
Manuals, guidelines, or literature 16 45.7% 21 48.8%
Web seminars 12 34.3% 11 25.6%
Consulting site visits 6 17.1% 11 25.6%
In-person or video conferences 5 14.3% 10 23.3%
Other 1 2.9% 1 2.3%
None reported 2 5.7% 9 20.9%
Type of consent procedure for HIV testingb
Opt in approach ONLY 18 51.4% 21 48.8%
Opt out approach ONLY 17 48.6% 3 7.0%
Combination of opt in and opt out 0 0.0% 19 44.2%
Type of HIV counseling offered with testing
Pre-test counseling only 1 2.9% 1 2.3%
Post-test counseling only 4 11.4% 7 16.3%
Both pre and post-test counseling 28 80.0% 30 69.8%
Neither pre nor post-test counseling 1 2.9% 5 11.6%
Other 1 2.9% 0 0.0%
Funding used by organization for HIV testingc
Local Health Department Funding (DC, Houston) 26 74.3% 10 23.3%
Texas DSHS N/A N/A 8 18.6%
CDC Funding 9 25.7% 3 7.0%
Other Federal Funding (Ryan White, Other HRSA, SAMHSA, VA) 11 31.4% 7 16.3%
Private Grant Funding 7 20.0% 8 18.6%
Research (HPTN 065/TLC Plus HIV testing or other research study) 12 34.3% 2 4.7%
Medicaid 10 28.6% 23 53.5%
Medicare 4 11.4% 14 32.6%
Patient/patient’s insurance 10 28.6% 28 65.1%
Other d 1 2.9% 14 32.6%
None reported 12 34.3% 0 0.0%
Funding used by organization for routine, opt out testing
(among those doing opt out testing)c
n= 35 n= 22
Local Health Department Funding (DC, Houston) 24 68.6% 4 18.2%
Texas DSHS N/A N/A 5 22.7%
CDC Funding 5 14.3% 0 0.0%
Other Federal Funding (Ryan White, Other HRSA, SAMHSA, VA) 6 17.1% 1 4.5%
Private Grant Funding 5 14.3% 6 27.3%
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Table 2. Cont.
Washington, DC (N=35) Houston, TX (N=43)
N % N %
Research (HPTN 065/TLC Plus HIV testing or other research study) 5 14.3% 0 0.0%
Medicaid 9 25.7% 11 50.0%
Medicare 4 11.4% 3 13.6%
Patient/patient’s insurance 7 20.0% 12 54.5%
Other e 1 2.9% 9 40.9%
None reported 6 17.1% 0 0.0%
HIV tests performed in 2011
Median (Range) Total No. of Tests Median (Range) Total No. of Tests
Rapid tests (DC n= 30; Houston n = 21) 593 (5–10,673) 78,765 1,478 (4–9,945) 40,910
Venipuncture tests (DC n = 3; Houston n= 34) 1200 (36–3,322) 4,558 585 (1.5–46,590)f 169,635
Total tests (DC n= 22; Houston n = 41) 568 (20–10,673) 41,085 1,045 (1.5–47,209)f 210,565
aCommunity service organizations include homeless services, substance abuse recovery centers, life skills programs, housing assistance programs, faith-based
organizations, and other community-oriented service organizations.
bFive organizations participating in the Houston survey only use opt-out consent during pregnancy as required by Texas law but do not use opt-out consent otherwise.
Therefore, the bulk of consent used for these organizations would be opt-in. Results if these organizations are re-classified into the ‘‘opt-in approach only’’ category: 26
(60.5%) organizations use opt-in approach only, 3 (7.0%) organizations use opt-out approach only, and 14 (32.6%) organizations use a combination of opt-in and opt-
out consent.
cRespondents could check more than one response.
dOther responses in DC include general revenue (n = 1). Other responses in Houston include donations (n = 12) and general revenue (n = 2).
eOther responses in DC include general revenue (n = 1). Other responses in Houston include donations (n = 8) and general revenue (n = 2). One Houston organization
selected both donations and general revenue for a total of n = 9 organizations selecting ‘‘other’’.
fOne Houston organization estimated 1–2 tests were completed. The average, 1.5 tests, was recorded as the response.
doi:10.1371/journal.pone.0110010.t002
Figure 1. Attitudinal barriers to HIV testing by City.
doi:10.1371/journal.pone.0110010.g001
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time (75.0%), staff size (75.0%), and lack of funding (66.7%). In
contrast, in Houston, hospitals reported the fewest barriers, while
clinics reported the most. The most frequent barriers among
Houston clinics included lack of funding (68.2%), refusal to get
tested (63.6%), cost/reimbursement (50.0%), and staff knowledge/
skill/experience (50.0%).
Discussion
Utilizing a framework of operational research for HIV
prevention, [25] this study identified differences and similarities
in the approaches two high prevalence cities have taken to
implement routine HIV testing. While both jurisdictions reported
a high level of provider education on HIV testing, many
organizations in both cities reported opt-in consent approaches
and pre-test counseling, suggesting the 2006 CDC recommenda-
tions are not being followed consistently. The cause of inconsis-
tency merits further research since statutes do not pose a
substantial barrier in either jurisdiction. [14] Previous implemen-
tation research has shown that this inconsistency may be due to 1)
a lack of awareness or misunderstanding of the recommendations,
[27,32,33] 2) disagreement with the recommendations, [34] and/
or 3) organizational barriers that impede application of the
recommendations. [27,28,30,35,36] Both cities may benefit from
further research into why organizations continue to use both pre-
and post-test counseling and do not use opt-out testing.
The two jurisdictions have taken different approaches to
support and fund the expansion of routine testing. DC DOH’s
approach has involved considerable funding for the distribution of
free rapid test kits to local implementation sites including clinics,
hospitals and CBOs. This is in contrast to the HDHHHS’
approach which has encouraged performing venipuncture tests as
part of routine visits and funding large volumes of HIV testing in
hospitals and clinics with rapid results of standard testing. [37]
This divergence of approaches is reflected in the greater total
number of rapid tests being utilized in DC and much greater total
number of venipuncture tests being performed in Houston.
Funding sources for testing also varied between the two
jurisdictions which could have implications for the long term
sustainability and scalability of these testing programs. Houston
testing organizations reported much more third party billing and
reimbursement from Medicaid, Medicare, and private insurance
as a primary means to support their testing programs, compared to
DC sites which relied much more heavily on direct support from
DC DOH. Because of this, Houston organizations may be better
positioned to more quickly adapt and benefit from expanded
coverage through the Affordable Care Act (ACA), especially now
that routine testing is rated a recommended service for coverage
by the US Public Health Services Task Force (USPHSTF).
However, this strong reliance on third party reimbursement does
leave these organizations more vulnerable to reimbursement
challenges and inadequate reimbursement rates that may not
cover the total cost of testing provision. The monitoring of HIV
testing post-ACA and USPHSTF implementation will allow for
further exploration of the impact of these policies on testing
programs.
Overall, few barriers to testing implementation were reported
by organizations in both jurisdictions however, among those
reported, lack of funding and organizational capacity to conduct
testing were key barriers. Capacity barriers, such as staff size and
Figure 2. Resources and funding barriers to HIV testing by City.
doi:10.1371/journal.pone.0110010.g002
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time were moderate barriers for the surveyed organizations and
may have been related to lack of funding to support these efforts at
the organizational level, particularly among organizations in DC.
Although multiple methods of routine HIV testing have been
promoted in DC, there is more reliance on rapid testing, which
can be more time and labor-intensive than venipuncture testing.
Time-related barriers and competing priorities have been exten-
sively reported in literature, [26–28,30,32,35,38,39] but research
has found that providers cite consent and counseling requirements
as time-intensive even when statutes have removed these barriers
in a jurisdiction. [26] Interestingly, despite the generalized
epidemic and high HIV prevalence in DC, a commonly reported
barrier included the perception that HIV was not a problem
among the patient population. This perception may depend on the
age of the population being served as a previous survey conducted
by DC DOH found that almost 40% of providers did not perceive
HIV to be a problem among those 50 years of age and older
[Michael Kharfen, personal communication]. Barriers elicited in
this study suggest that DC may benefit from campaigns that
emphasize the necessity of HIV testing, while Houston may benefit
from increasing testing knowledge and skill among providers.
Patient discomfort or refusal for testing was a barrier in both cities
and has been reported by providers elsewhere [26,27,39] with
clients often refusing due to low-perceived risk for HIV, recent
testing elsewhere, [40,41] fear of loss, fatalism, confidentiality
concerns, and structural barriers. [36] Future qualitative research
in both DC and Houston, focusing first on the commonly reported
barriers presented here, may best elicit additional barriers and
facilitators of sustained HIV testing.
This study determined current implementation practices and
perceived barriers to HIV testing, a crucial step to design
interventions and guide policy to improve HIV testing in cities
with a high burden of HIV, such as DC and Houston. In 2010,
New York State enacted a statute requiring primary care settings
to offer HIV testing to all patients between the ages of 13 to 64.
Since this law was enacted, one study found that only 65% of
emergency departments implemented HIV testing as required by
the law. [8] While changes to policy guidance at the jurisdictional
level may increase testing, [42] statute alone is not the solution.
[8,35] Further increases in testing uptake may be realized with
policy change and implementation at the organizational level,
[43,44] especially in jurisdictions with low uptake such as some
organizations in Houston. Organizational leadership to drive local
policy formulation, revision, and implementation is critical. Other
facilitators include organizational buy-in from both providers and
administration, [27,28] written procedures for HIV testing, [30]
provider trainings, [27] and dedicated staff and funding. [35]
There are a number of limitations to this study. The survey was
a convenience sample that could be subject to non-response bias.
The self-reported responses were limited to the organizational
knowledge, perceptions and/or experiences of the person com-
pleting the survey, thus the responses may not accurately reflect
the practices or opinions of all providers or staff members. The
primary limitation of the parts of this study that compared DC and
Houston was differences in survey administration between the two
cities. Non-response was potentially influenced in Houston (65.5%
vs. 85.4% in DC) by the lack of compensation for survey
completion. The differing routes of survey administration (in-
person in Houston and online in DC) may have also led to
Figure 3. Staff capacity barriers to HIV testing by City.
doi:10.1371/journal.pone.0110010.g003
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variances in social desirability or comprehension of the survey
questions. In addition, social desirability may have biased the
results, especially in reporting of testing barriers. Furthermore, our
ability to statistically analyze barrier data was limited as many of
the barriers received low rankings. Finally, generalizability of these
findings may be limited, particularly in jurisdictions that have
statutes in conflict with the 2006 CDC recommendations. Results
presented herein may be useful to such jurisdictions after their
statutes transition.
Despite both DC and Houston having high HIV prevalence,
each jurisdiction has tailored their HIV testing strategies to meet
particular funding options, resources, and statutes. The range of
approaches was appropriate given the distinct context of the
epidemic in each jurisdiction. Reported implementation practices,
such as types of tests used and the funding mechanisms most often
used to pay for HIV testing, highlight this variation. Regardless of
different implementation approaches, our results suggest many
organizations in at least two high burden jurisdictions have not
aligned with all aspects of national testing recommendations.
Research has shown that neither awareness of CDC guidelines nor
jurisdictional policy change alone fully scales up testing to the
levels recommended in the 2006 guidelines. [8,32,39] It is likely
that a multi-faceted approach is needed that includes awareness
campaigns, policy change, and reduction of jurisdictional and
organizational-specific barriers. Few multi-faceted approaches
have been rigorously evaluated to determine if they can widely
span multiple jurisdictions with diverse epidemics, policy, and
resources. Further implementation research and dissemination of
implementation research findings is critical to the expansion of
routine HIV testing and early diagnosis of HIV infection.
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